These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 25950156)

  • 1. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
    Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
    Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
    Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
    Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand.
    Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A
    Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotin-Pt(IV)-Ru(II)-Boron-Dipyrromethene Prodrug as "Platin Bullet" for Targeted Chemo- and Photodynamic Therapy.
    Bera A; Nepalia A; Upadhyay A; Saini DK; Chakravarty AR
    Inorg Chem; 2024 Sep; 63(37):17249-17262. PubMed ID: 39235210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and biomolecular responses of human ovarian cancer cells to cytostatic dinuclear platinum(II) complexes.
    Lin M; Wang X; Zhu J; Fan D; Zhang Y; Zhang J; Guo Z
    Apoptosis; 2011 Mar; 16(3):288-300. PubMed ID: 21107699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.
    Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
    Inorg Chem; 2014 Jun; 53(12):6113-26. PubMed ID: 24884156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ru
    Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
    Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
    J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes.
    Dömötör O; de Almeida RF; Côrte-Real L; Matos CP; Marques F; Matos A; Real C; Kiss T; Enyedy ÉA; Helena Garcia M; Tomaz AI
    J Inorg Biochem; 2017 Mar; 168():27-37. PubMed ID: 28006663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo.
    Shu L; Ren L; Wang Y; Fang T; Ye Z; Han W; Chen C; Wang H
    Chem Commun (Camb); 2020 Mar; 56(20):3069-3072. PubMed ID: 32049075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
    Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
    Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, DNA interaction, antioxidant and anticancer activity studies of ruthenium(II) polypyridyl complexes.
    Jiang GB; Xie YY; Lin GJ; Huang HL; Liang ZH; Liu YJ
    J Photochem Photobiol B; 2013 Dec; 129():48-56. PubMed ID: 24177204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hetero-multinuclear ruthenium(III)/platinum(II) complexes that potentially exhibit both antimetastatic and antineoplastic properties.
    Anderson CM; Taylor IR; Tibbetts MF; Philpott J; Hu Y; Tanski JM
    Inorg Chem; 2012 Dec; 51(23):12917-24. PubMed ID: 23150984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.